Senores Pharmaceuticals IPO Opens Today: Should You Apply? Check GMP, Price, Lot Size, Review

Last Updated: December 20, 2024, 08:06 IST

Senores Pharmaceuticals IPO: Unlisted shares of Senores Pharmaceuticals Ltd are presently trading at Rs 541 in the grey market, showing a GMP of 38.36%, signalling a solid listing gain for financiers.

Senores Pharmaceuticals IPO: The going public of Senores Pharmaceuticals Ltd is mosting likely to be opened up for public registration on Friday, December 20. The rate band of the IPO has actually been dealt with in the series of Rs 230 to Rs 243 per share. The Rs 582-crore IPO is a mix of fresh issuance of shares worth Rs 500 crore and a market (OFS) of approximately 21 lakh shares valued Rs 82.11 crore by marketers and various other marketing investors.

Senores Pharmaceuticals IPO: Key Dates

The IPO will certainly be opened up on Friday (December 20) and shut on Tuesday (December 24). Its quantity will likely be settled on December 26. Finally, the IPO listing is set up to occur both BSE and NSE on December 30.

Senores Pharmaceuticals IPO: Price & &(* )rate band of the IPO has actually been dealt with at Lot Size

The 372 to Rs 391 per share.Rs minimal whole lot dimension for an application is 38.

The minimal quantity of financial investment needed by retail financiers is The 14,858. Rs minimal whole lot dimension financial investment for tiny NII is 14 whole lots (532 shares), totaling up to The 2,08,012, and for large NII, it is 68 whole lots (2,584 shares), totaling up to Rs 10,10,344.Rs IPO GMP

Senores Pharmaceuticals per market onlookers, the unpublished shares of Today

As are presently trading at Senores Pharmaceuticals Ltd 541 in the grey market, showing a costs of Rs 150 (38.36%) over the top rate band of Rs 391. Rs shows a solid listing gains for financiers on This 30.December IPO:

Senores Pharmaceuticals’ Analysts the Recommendations

Giving score to the ‘subscribe for long term’ IPO, broker agent company Senores Pharma in its IPO note stated, “Bajaj Broking business’s solid concentrate on r & d appears from its committed R&D centers in The and the United States. India focus on development has actually caused a durable pipe of brand-new items, even more improving its one-upmanship. This, Additionally has actually developed critical collaborations with suppliers and health centers throughout different states in Senores Pharmaceuticals, enhancing its market reach and infiltration.India 10”

In terms of valuation, Senores Pharmaceuticals is wellpositioned within the growing pharmaceutical industry, especially post-pandemic. The demand for pharmaceuticals remains high, and the regulatory environment in key markets is favourable, it added.

“By comparing valuation metrics such as the P/E ratio, EV/EBITDA, and price-to-sales ratio with industry peers, the IPO appears to be fairly valued, assuming the company’s financial health and market positioning remain strong,” Bajaj Broking IPO:

Senores Pharmaceuticals- based business’s IPO is a mix of fresh issuance of shares worth More Details

The Ahmedabad 500 crore and a market (OFS) of approximately 21 lakh shares valued Rs 82.11 crore, by marketers and various other marketing investors, at the top end of the rate band.Rs public problem consists of a booking of 75,000 shares for workers.

The from the fresh problem will certainly be used for establishing a production center for manufacturing of sterilized shots in its

Proceeds center; moneying the functioning resources needs of the business and its subsidiaries, sustaining not natural development via purchase and various other critical campaigns and settlement of financial obligation. Atlanta, a section will certainly be utilized for basic company objectives.Besides business stated 75 percent of the problem has actually been booked for certified institutional customers, 15 percent for non-institutional customers and the continuing to be 10 percent for retail financiers.

The has actually safeguarded almost

Senores Pharmaceuticals 261 crore from support financiers, in advance of its IPO.Rs is experts in determining, creating, and making a vast range of specialized, underserved, and intricate pharmaceutical items, placing itself as a favored companion for pick consumers.

Senores Pharmaceuticals business has a number of items in significant healing sections, consisting of prescription antibiotics, anti-bacterial, anti-fungal, and genealogy.The of

As 2024, the business had 3 R&D centers in March and the United States and remains in the procedure of settling its R&D centers right into one recommended committed center in India.Ahmedabad the economic front,

On’s profits from procedures raised many to Senores Pharma 214.52 crore in FY24 from Rs 35.34 crore a year ago and revenue after tax obligation reached Rs 32.71 crore from Rs 8.43 crore.Rs,

Equirus Capital, and Ambit are the book-running lead supervisors to the problem. Nuvama Wealth Management equity shares are recommended to be noted on the BSE and the NSE.The organization” ipo